Assessing Factors Associated With Patient-Provider Discussions About Lung Cancer Screening Using Andersen's Behavioral Model of Health Services Utilization.
Owen Y Cai, Jessica R Fernandez, Melinda C Aldrich, Jennifer Richmond
{"title":"Assessing Factors Associated With Patient-Provider Discussions About Lung Cancer Screening Using Andersen's Behavioral Model of Health Services Utilization.","authors":"Owen Y Cai, Jessica R Fernandez, Melinda C Aldrich, Jennifer Richmond","doi":"10.1016/j.cllc.2025.06.006","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patient-provider shared decision-making discussions are an important component of lung cancer screening guidelines, but little is known about factors associated with these discussions among screening-eligible patients. We used Andersen's Behavioral Model of Health Services Utilization to examine factors associated with discussing LCS with a provider.</p><p><strong>Patients: </strong>Data came from an online survey of N = 516 U.S. adults meeting United States Preventive Services Task Force LCS eligibility criteria (ie, were 50-80 years of age and had at least a 20-pack year history of tobacco use).</p><p><strong>Methods: </strong>We used logistic regression to investigate whether having a LCS discussion was associated with predisposing factors (eg, chronic obstructive pulmonary disease [COPD] diagnosis), enabling factors (eg, having a primary care provider [PCP]), and need factors (eg, smoking history).</p><p><strong>Results: </strong>About 36% participants had ever discussed LCS with a provider. Participants diagnosed with COPD (OR = 3.56, 95% CI, 1.90-6.67) and who had a first-degree relative with lung cancer (OR = 1.78, 95% CI, 1.02-3.09) had higher odds of LCS discussion than those without COPD and with no family history, respectively. Women had lower odds of LCS discussion than men (OR = 0.37, 95% CI, 0.24-0.58). Participants with an income of $30,000 to $59,999 had higher odds of LCS discussion compared to those earning < $30,000 (OR = 1.78, 95% CI, 1.06-2.98). Not having a PCP (OR = 0.39, 95% CI, 0.21-0.72) and currently smoking (OR = 0.38, 95% CI, 0.18-0.79) were associated with lower odds of LCS discussion.</p><p><strong>Conclusions: </strong>Future interventions are needed to ensure all LCS-eligible individuals have access to provider discussions about LCS.</p>","PeriodicalId":10490,"journal":{"name":"Clinical lung cancer","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12306795/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical lung cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cllc.2025.06.006","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Patient-provider shared decision-making discussions are an important component of lung cancer screening guidelines, but little is known about factors associated with these discussions among screening-eligible patients. We used Andersen's Behavioral Model of Health Services Utilization to examine factors associated with discussing LCS with a provider.
Patients: Data came from an online survey of N = 516 U.S. adults meeting United States Preventive Services Task Force LCS eligibility criteria (ie, were 50-80 years of age and had at least a 20-pack year history of tobacco use).
Methods: We used logistic regression to investigate whether having a LCS discussion was associated with predisposing factors (eg, chronic obstructive pulmonary disease [COPD] diagnosis), enabling factors (eg, having a primary care provider [PCP]), and need factors (eg, smoking history).
Results: About 36% participants had ever discussed LCS with a provider. Participants diagnosed with COPD (OR = 3.56, 95% CI, 1.90-6.67) and who had a first-degree relative with lung cancer (OR = 1.78, 95% CI, 1.02-3.09) had higher odds of LCS discussion than those without COPD and with no family history, respectively. Women had lower odds of LCS discussion than men (OR = 0.37, 95% CI, 0.24-0.58). Participants with an income of $30,000 to $59,999 had higher odds of LCS discussion compared to those earning < $30,000 (OR = 1.78, 95% CI, 1.06-2.98). Not having a PCP (OR = 0.39, 95% CI, 0.21-0.72) and currently smoking (OR = 0.38, 95% CI, 0.18-0.79) were associated with lower odds of LCS discussion.
Conclusions: Future interventions are needed to ensure all LCS-eligible individuals have access to provider discussions about LCS.
期刊介绍:
Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.